title: Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum.
abstract: Microexplant cultures from three-day-old rats were used to investigate whether angiotensin II (Ang II), through its AT(1) and AT(2) receptors, could be involved in the morphological differentiation of cerebellar cells. Specific activation of the AT(2) receptor during 4-day treatment induced two major morphological changes. The first was characterized by increased elongation of neurites. The second change was cell migration from the edge of the microexplant toward the periphery. Western blot analyses and indirect immunofluorescence studies revealed an increase in the expression of neuron-specific betaIII-tubulin, as well as an increase in expression of the microtubule-associated proteins tau and MAP2. These effects were demonstrated by co-incubation of Ang II with 1 microM DUP 753 (AT(1) receptor antagonist) or with 10 nM CGP 42112 (AT(2) receptor agonist) but abolished when Ang II was co-incubated with 1 microM PD 123319 (AT(2) receptor antagonist), indicating that differentiation occurs through AT(2) receptor activation and that the AT(1) receptor inhibits the AT(2) effect. Taken together, these results demonstrate that Ang II is involved in cerebellum development for both neurite outgrowth and cell migration, two important processes in the organization of the various layers of the cerebellum.
authors.affiliation: Service of Endocrinology, Faculty of Medicine, University of Sherbrooke, Sherbrooke Quebec J1H 5N4, Canada.
authors.forename: F
authors.initials: F
authors.lastname: Côté
authors.forename: T H
authors.initials: TH
authors.lastname: Do
authors.forename: L
authors.initials: L
authors.lastname: Laflamme
authors.forename: J M
authors.initials: JM
authors.lastname: Gallo
authors.forename: N
authors.initials: N
authors.lastname: Gallo-Payet
mesh_terms: D000804:Angiotensin II / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D015153:Blotting, Western; D002454:Cell Differentiation; D002465:Cell Movement; D002531:Cerebellum / Q000166:cytology* / Q000187:drug effects; D046508:Culture Techniques; D019084:Fluorescent Antibody Technique, Indirect; D007093:Imidazoles / Q000494:pharmacology; D019808:Losartan; D008869:Microtubule-Associated Proteins / Q000096:biosynthesis; D016501:Neurites; D009842:Oligopeptides / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D020318:Rats, Long-Evans; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin / Q000819:agonists / Q000378:metabolism*; D015398:Signal Transduction; D014404:Tubulin / Q000378:metabolism; D016875:tau Proteins / Q000378:metabolism
chemical_list: D057911:Angiotensin Receptor Antagonists; D007093:Imidazoles; D008869:Microtubule-Associated Proteins; D009842:Oligopeptides; D011725:Pyridines; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011945:Receptors, Angiotensin; D014404:Tubulin; D016875:tau Proteins; D000804:Angiotensin II; C060894:CGP 42112A; C073402:PD 123319; D019808:Losartan